| Product Code: ETC7377642 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Personalized Cancer Vaccines Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Personalized Cancer Vaccines Market - Industry Life Cycle |
3.4 Grenada Personalized Cancer Vaccines Market - Porter's Five Forces |
3.5 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.7 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By Bio-Maker Type, 2021 & 2031F |
3.9 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.10 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Grenada Personalized Cancer Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Grenada Personalized Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Grenada |
4.2.2 Growing awareness about personalized cancer treatment options |
4.2.3 Advancements in technology for developing personalized cancer vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with personalized cancer vaccines |
4.3.2 Limited access to specialized healthcare facilities in Grenada |
4.3.3 Regulatory challenges and approval processes for personalized cancer vaccines |
5 Grenada Personalized Cancer Vaccines Market Trends |
6 Grenada Personalized Cancer Vaccines Market, By Types |
6.1 Grenada Personalized Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.7 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.8 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2 Grenada Personalized Cancer Vaccines Market, By Mechanism of Action Type |
6.2.1 Overview and Analysis |
6.2.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-associated Antigens (TAAs), 2021- 2031F |
6.2.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-specific Antigens (TSAs), 2021- 2031F |
6.2.4 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Somatic Mutations in Cancer Pharmacogenomics, 2021- 2031F |
6.2.5 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics towards Genomic Polymorphism, 2021- 2031F |
6.3 Grenada Personalized Cancer Vaccines Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Dendritic Cells (DC) Cancer Vaccines, 2021- 2031F |
6.3.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Recombinant Cancer Vaccines, 2021- 2031F |
6.3.4 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Antigen/Adjuvant Cancer Vaccines, 2021- 2031F |
6.3.5 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Viral Vector and DNA Cancer Vaccines, 2021- 2031F |
6.4 Grenada Personalized Cancer Vaccines Market, By Bio-Maker Type |
6.4.1 Overview and Analysis |
6.4.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.4.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Prognostic and Predictive Biomarkers, 2021- 2031F |
6.4.4 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Immune Checkpoint Biomarkers, 2021- 2031F |
6.4.5 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Grenada Personalized Cancer Vaccines Market, By Treatment Type |
6.5.1 Overview and Analysis |
6.5.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Preventive Cancer Vaccines, 2021- 2031F |
6.5.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Therapeutic Cancer Vaccines, 2021- 2031F |
6.6 Grenada Personalized Cancer Vaccines Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Injectables, 2021- 2031F |
6.6.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Grenada Personalized Cancer Vaccines Market, By End Users |
6.7.1 Overview and Analysis |
6.7.2 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Grenada Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Personalized Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Grenada Personalized Cancer Vaccines Market Export to Major Countries |
7.2 Grenada Personalized Cancer Vaccines Market Imports from Major Countries |
8 Grenada Personalized Cancer Vaccines Market Key Performance Indicators |
8.1 Number of clinical trials and research studies on personalized cancer vaccines in Grenada |
8.2 Percentage of oncologists recommending personalized cancer vaccines to patients |
8.3 Investment in research and development for personalized cancer vaccines in Grenada |
9 Grenada Personalized Cancer Vaccines Market - Opportunity Assessment |
9.1 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.3 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By Bio-Maker Type, 2021 & 2031F |
9.5 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.6 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Grenada Personalized Cancer Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Grenada Personalized Cancer Vaccines Market - Competitive Landscape |
10.1 Grenada Personalized Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Grenada Personalized Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here